A shorter duration of diabetes, lower HbA1c level and lower BMI at genetic diagnosis predicted successful treatment with sulfonylurea/diet alone in participants with HNF1A/HNF4A-MODY, supporting the need for early genetic diagnosis and treatment change. The gene discussed is HNF4A; the disease is diabetes mellitus.